Community-Acquired Pneumonia Diagnosis

Limitations of Etiological Diagnosis

The American Thoracic Society notes that clinical characteristics of community-acquired pneumonia (CAP) cannot be used reliably to establish a specific etiological diagnosis with adequate sensitivity and specificity 1
The traditional classification of pneumonia into "typical" and "atypical" has limited clinical value, as it represents a clinical syndrome that includes diverse entities 1
Atypical pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella can cause a wide range of clinical manifestations that overlap with those caused by typical bacterial pathogens 2
Host factors such as advanced age and coexisting diseases significantly affect the clinical presentation, making etiological differentiation even more difficult 1

Up to 50% of patients with CAP do not have the responsible pathogen identified, even with extensive diagnostic evaluation 3
No single available test can identify all potential pathogens, and each diagnostic test has limitations 3
Gram stain and sputum culture may be discordant for the presence of Streptococcus pneumoniae and do not detect frequent pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella 3

Current guidelines recommend an empirical approach based on disease severity, patient risk factors, and local epidemiology, without the need to initially specify whether CAP is bacterial or not 4, 5
Antibiotic treatment is directed empirically against the major bacterial pathogens causing CAP: Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Staphylococcus aureus, Legionella species, Chlamydia pneumoniae, and Moraxella catarrhalis 4
The microbial etiology of CAP is changing, particularly with the widespread introduction of the pneumococcal conjugate vaccine, and there is increasing recognition of the role of viral pathogens 4

In patients with severe disease that does not respond to initial empirical treatment 2
In cases of epidemic outbreaks or when there are public health implications (such as Legionella infections) 3
In immunocompromised patients, who require a more extensive diagnostic approach 2
When resistant pathogens are identified that may require adjustments in therapy 3

The American Thoracic Society recommends diagnosing CAP based on clinical signs/symptoms plus radiographic confirmation, with chest X-ray being the standard for confirming pneumonia, though clinical diagnosis alone is acceptable in mild outpatient cases 6, 7
The American Thoracic Society suggests that routine sputum cultures or blood cultures should not be obtained in outpatients, and should be reserved for specific high-risk situations only 6
The American Thoracic Society recommends against routine urine antigen testing for pneumococcus or Legionella in outpatients 8

The Infectious Diseases Society of America recommends using validated severity scores, such as PSI or CURB-65, to determine hospitalization need and treatment intensity 9
The American Thoracic Society defines severe CAP criteria, which includes septic shock requiring vasopressors or respiratory failure requiring mechanical ventilation, and recommends obtaining pretreatment sputum cultures, blood cultures, and urine antigens in these patients 6, 8

The American Thoracic Society recommends initiating empiric antibiotics immediately based on severity and risk factors, without delaying for diagnostic testing, and suggests that β-lactam plus macrolide combination has stronger evidence than β-lactam plus fluoroquinolone 6, 8, 9
The American Thoracic Society recommends adding MRSA coverage if there is a prior MRSA infection, recent hospitalization with IV antibiotics, or high local MRSA prevalence 6, 8
The American Thoracic Society recommends adding Pseudomonas coverage if there is a prior Pseudomonas infection, structural lung disease, or recent hospitalization with IV antibiotics 6

The American Thoracic Society recommends a minimum of 5 days of therapy for all patients, with clinical stability required before discontinuation, and suggests that corticosteroids should not be routinely used, except in refractory septic shock or severe CAP 8
The American Thoracic Society recommends against routine follow-up chest radiographs in patients who achieve clinical stability, but suggests considering lung cancer screening if the patient meets eligibility criteria 8